Surgical characteristics and complications | the morcellator group (n = 105) | the control group (n = 117) | p |
---|---|---|---|
Surgical time (min, mean ± SD) | 102.0 ± 42.6 | 115.7 ± 53.6 | 0.039 |
Mean estimated blood loss (ml, mean ± SD) | 118.6 ± 105.6 | 151.4 ± 108.4 | 0.025 |
Hospitalization time (day, mean ± SD) | 4.6 ± 1.2 | 4.9 ± 1.5 | >0.05 |
Surgical complications (n, %) | 8(7.6) | 11(9.4) | >0.05 |
Peritoneum injury | 6(5.7) | 7(6.0) | |
Wound infection | 2(1.9) | 4(3.4) | |
Obese patients((BMI ≥ 28, n, %) | 31(29.5%) | 36 (30.8%) | |
Surgical time (min, mean ± SD) | 120.2 ± 18.8 | 141.5 ± 17.6 | <0.001 |
Mean estimated blood loss (ml, mean ± SD) | 127.6 ± 47.6 | 163.3 ± 59.2 | 0.007 |
high-volume tumors (Stage T2a, sn, %) | 26 (24.8%) | 28 (23.9%) | |
Surgical time (min, mean ± SD) | 152.7 ± 26.3 | 172.9 ± 17.6 | 0.001 |
Mean estimated blood loss (ml, mean ± SD) | 209.6 ± 45.7 | 237.7 ± 61.7 | <0.001 |